Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis.

about

Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis.

Item

http://www.wikidata.org/entity/Q51039671

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Identification and quantificat ...... trophoresis in AL amyloidosis.

@en

Identification and quantificat ...... trophoresis in AL amyloidosis.

@nl

type

Item

label

Identification and quantificat ...... trophoresis in AL amyloidosis.

@en

Identification and quantificat ...... trophoresis in AL amyloidosis.

@nl

prefLabel

Identification and quantificat ...... trophoresis in AL amyloidosis.

@en

Identification and quantificat ...... trophoresis in AL amyloidosis.

@nl

P1476

Identification and quantificat ...... ctrophoresis in AL amyloidosis

@en

P2093

Andrea Foli

http://www.w3.org/2001/XMLSchema#string

Fabrizio Belvisi

http://www.w3.org/2001/XMLSchema#string

Filomena Li Bergolis

http://www.w3.org/2001/XMLSchema#string

Francesca Russo

http://www.w3.org/2001/XMLSchema#string

Giampaolo Merlini

http://www.w3.org/2001/XMLSchema#string

Giorgio Consogno

http://www.w3.org/2001/XMLSchema#string

Giovanni Ferraro

http://www.w3.org/2001/XMLSchema#string

Laura Pirolini

http://www.w3.org/2001/XMLSchema#string

Marco Basset

http://www.w3.org/2001/XMLSchema#string

Margherita Bozzola

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Screening panels for detection of monoclonal gammopathies.

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

P304

66-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13506129.2017.1293643

http://www.w3.org/2001/XMLSchema#string

P433

sup1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28434323

http://www.w3.org/2001/XMLSchema#string